Preprint: The Economic Burden of KCNT1-Related Disorders in the United States: Insights from Caregiver-Reported and EMR-Derived Data

WHY IT MATTERS

If you have a child with KCNT1-related epilepsy, this research documents the financial burden your family faces and provides evidence that could support insurance coverage decisions and funding for new treatments.

Researchers studied how much money families and the healthcare system spend on KCNT1-related disorders, a rare genetic brain condition that causes severe seizures starting in early childhood. The study used information from both families caring for patients and medical records to understand the true financial costs. This is important because there are currently no approved treatments that can change the course of the disease, so families face lifelong expensive care.

The Economic Burden of KCNT1-Related Disorders in the United States: Insights from Caregiver-Reported and EMR-Derived Data Authors: Abuhl, A. et al. Server: medRxiv Category: health economics Abstract: BackgroundKCNT1-related disorders are a rare, severe neurogenetic disorder associated with early-onset, treatment-resistant seizures and significant developmental comorbidities. Currently there are no treatment-modifying therapeutics for this condition, and the condition necessitates complex, lifelong care that places a profound financial strain on affected families and healthcare systems. However, data quantifying this economic burden is sparse. ObjectiveTo evaluate the annual cost burden of KCNT1-related disorders in the United States using both caregiver-reported expenditures and electroni